Spur Exim Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 1.50 M
- Revenue Growth -97.21%
- Profit Growth -12143.85%
- Ebitda -132.31%
- Net Worth -59.33%
- Total Assets 0.69%
About Spur Exim
Spur Exim Private Limited (SEPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 December 2009 and has a history of 15 years and two months. Its registered office is in Raipur, Chattisgarh, India.
The Corporate was formerly known as Atharv Remedies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Umesh Upadhyay and Smita Upadhyay serve as directors at the Company.
Company Details
- Location
Raipur, Chattisgarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230CT2009PTC021493
- Company No.
021493
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2009
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
What products or services does Spur Exim Private Limited offer?
Spur Exim Private Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Cefixime and Lactic Acid Bacillus Tablets, Allopathic Cough Syrup, Ambroxol Hydrochloride Syrup, Vitamin Tablets & Capsules, Methylcobalamin Tablets, Calcitriol Capsules, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Antiviral Drugs.
Who are the key members and board of directors at Spur Exim?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Upadhyay  | Director | 14-Dec-2009 | Current |
| Smita Upadhyay | Director | 18-Dec-2009 | Current |
Financial Performance of Spur Exim.
Spur Exim Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 97.21% decrease. The company also saw a substantial fall in profitability, with a 12143.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 59.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spur Exim?
In 2020, Spur Exim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹1.50 M
Charges Breakdown by Lending Institutions
- Indian Bank : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Dec 2014 | Indian Bank | ₹1.50 M | Satisfied |
How Many Employees Work at Spur Exim?
Unlock and access historical data on people associated with Spur Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spur Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spur Exim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
